This dual inhibition provides a mechanistic explanation for the anti-inflammatory effects of HEP on AD, where dysregulated NF-κB and JAK/STAT signaling drive keratinocyte-mediated inflammation and epidermal barrier dysfunction. The gene discussed is SOAT1; the disease is Alzheimer disease.